6-154414407-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173515.4(CNKSR3):c.962C>T(p.Ala321Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000157 in 1,596,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173515.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNKSR3 | NM_173515.4 | c.962C>T | p.Ala321Val | missense_variant | 10/13 | ENST00000607772.6 | NP_775786.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNKSR3 | ENST00000607772.6 | c.962C>T | p.Ala321Val | missense_variant | 10/13 | 1 | NM_173515.4 | ENSP00000475915.1 | ||
ENSG00000288520 | ENST00000673182.1 | c.962C>T | p.Ala321Val | missense_variant | 10/22 | ENSP00000499846.1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152100Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000108 AC: 25AN: 232076Hom.: 0 AF XY: 0.000152 AC XY: 19AN XY: 125090
GnomAD4 exome AF: 0.000164 AC: 237AN: 1444774Hom.: 0 Cov.: 31 AF XY: 0.000162 AC XY: 116AN XY: 717934
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152100Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.962C>T (p.A321V) alteration is located in exon 10 (coding exon 10) of the CNKSR3 gene. This alteration results from a C to T substitution at nucleotide position 962, causing the alanine (A) at amino acid position 321 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at